EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 39 (Novembre 2023) Hors série n° 1 Med Sci (Paris), 39 (2023) 37-46 References
Free Access
Issue
Med Sci (Paris)
Volume 39, Novembre 2023
Les Cahiers de Myologie
Page(s) 37 - 46
Section Mises au point
DOI https://doi.org/10.1051/medsci/2023133
Published online 17 November 2023
  1. Schwartz O, Jampel RS. Congenital blepharophimosis associated with a unique generalized myopathy. Arch Ophthal 1962 ; 68 : 52–57. [CrossRef] [PubMed] [Google Scholar]
  2. Catel W. Differentialdiagnostiche Symptomatologie von Krankheiten des Kinderalters. Stuttgart : George Thieme Ed, 1951 : 48–52. [Google Scholar]
  3. Aberfeld DC, Hinterbuchner LP, Schneider M. Myotonia, dwarfism, diffuse bone disease and unusual ocular and facial abnormalities (a new syndrome). Brain 1965 ; 88 : 313–322. [CrossRef] [PubMed] [Google Scholar]
  4. Huttenlocher PR, Landwirth J, Hanson V, et al. Osteo-chondro-muscular dystrophy. A disorder manifested by multiple skeletal deformities, myotonia, and dystrophic changes in muscle. Pediatrics 1969 ; 44 : 945–958. [CrossRef] [PubMed] [Google Scholar]
  5. Mereu TR, Porter IH, Hug G. Myotonia, shortness of stature, and hip dysplasia. Am J Dis Child 1969 ; 117 : 470–478. [CrossRef] [PubMed] [Google Scholar]
  6. Aberfeld DC, Namba T, Vye MV, et al. Chondrodystrophic myotonia: report of two cases: myotonic dwarfism, diffuse bone disease, and unusual ocular and facial abnormalities. Arch Neurol 1970 ; 22 : 455–462. [CrossRef] [PubMed] [Google Scholar]
  7. Aberfeld DC. Chondrodystrophic myotonia versus Schwartz-Jampel syndrome (Letter). Ann Neurol 1979 ; 5 : 210. [CrossRef] [PubMed] [Google Scholar]
  8. Beighton P.. The Schwartz syndrome in southern Africa. Clin Genet 1973 ; 4 : 548–555. [CrossRef] [PubMed] [Google Scholar]
  9. Fowler WM, Layzer RB, Taylor RG, et al. The Schwartz-Jampel syndrome: its clinical, physiological and histological expressions. J Neurol Sci 1974 ; 22 : 127–146. [CrossRef] [PubMed] [Google Scholar]
  10. van Huffelen AC, Gabreels FJM, van Luypen-van den Horst JS, et al. Chondrodystrophic myotonia: a report of two unrelated Dutch patients. Neuropadiatrie 1974 ; 5 : 71–90. [CrossRef] [Google Scholar]
  11. Pavone L, Mollica F, Grasso A, et al. Schwartz-Jampel syndrome in two daughters of first cousins. J Neurol Neurosurg Psychiat 1978 ; 41 : 161–169. [CrossRef] [PubMed] [Google Scholar]
  12. Cao A, Cianchetti C, Calisti L, et al. Schwartz-Jampel syndrome: clinical electrophysiological and histopathological study of a severe variant. J Neurol Sci 1978 ; 35 : 175–187. [CrossRef] [PubMed] [Google Scholar]
  13. Scaff M, Mendonca LIZ, Levy JA, et al. Chondrodystrophic myotonia: electromyographic and cardiac features of a case. Acta Neurol Scand 1979 ; 60 : 243–249. [Google Scholar]
  14. Edwards WC, Root AW. Chondrodystrophic myotonia (Schwartz-Jampel syndrome): report of a new case and follow-up of patients initially reported in 1969. Am J Med Genet 1982 ; 13 : 51–56. [CrossRef] [PubMed] [Google Scholar]
  15. Moodley M, Moosa A. Chondrodystrophic myotonia (Schwartz-Jampel syndrome) in South African children. Neuropediatrics 1990 ; 21 : 206–210. [CrossRef] [PubMed] [Google Scholar]
  16. Viljoen D, Beighton P. Schwartz-Jampel syndrome (chondrodystrophic myotonia). J Med Genet 1992 ; 29 : 58–62. [CrossRef] [PubMed] [Google Scholar]
  17. Pinto-Escalante D, Ceballos-Quintal JM, Canto-Herrera J. Identical twins with the classical form of Schwartz-Jampel syndrome. Clin Dysmorph 1997 ; 6 : 45–49. [Google Scholar]
  18. Pascuzzi RM, Gratianne R, Azzarelli B, et al. Schwartz-Jampel syndrome with dominant inheritance. Muscle Nerve 1990 ; 13 : 1152–1163. [CrossRef] [PubMed] [Google Scholar]
  19. Nicole S, Ben Hamida C, Beighton P, et al. Localization of the Schwartz-Jampel syndrome (SJS) locus to chromosome 1p34-p36.1 by homozygosity mapping. Hum Mol Genet 1995 ; 4 : 1633–1636. [CrossRef] [PubMed] [Google Scholar]
  20. Giedion A, Boltshauser E, Briner J, et al. Heterogeneity in Schwartz-Jampel chondrodystrophic myotonia. Eur J Pediat 1997 ; 156 : 214–223. [CrossRef] [PubMed] [Google Scholar]
  21. Nicole S, Davoine CS, Topaloglu H, et al. Perlecan, the major proteoglycan of basement membranes, is altered in patients with Schwartz-Jampel syndrome (chondrodystrophic myotonia). Nat Genet 2000 ; 26 : 480–483. [CrossRef] [PubMed] [Google Scholar]
  22. Arikawa-Hirasawa E, Le AH, Nishino I, et al. Structural and functional mutations of the perlecan gene cause Schwartz-Jampel syndrome, with myotonic myopathy and chondrodysplasia. Am J Hum Genet 2002 ; 70 : 1368–1375. [CrossRef] [PubMed] [Google Scholar]
  23. Dagoneau N, Scheffer D, Huber C, et al. Null leukemia inhibitory factor receptor (LIFR) mutations in Stüve-Wiedemann/Schwartz-Jampel Type 2 syndrome. Am J Hum Genet 2004 ; 74 : 298–305. [CrossRef] [PubMed] [Google Scholar]
  24. Arya R, Sharma S, Gupta N, et al. Schwartz Jampel syndrome in children. J Clin Neurosci 2013 ; 220 : 313–317. [CrossRef] [PubMed] [Google Scholar]
  25. Bastola P.Schwartz-Jampel syndrome. Kathmandu Univ Med J 2010 ; 8 : 348–351. [Google Scholar]
  26. Padmanabha H, Suthar R, Sankhyan N, et al. Stiffness, facial dysmorphism, and skeletal abnormalities: Schwartz-Jampel syndrome 1A. J Pediatr 2018 ; 200 : 286.e1. [CrossRef] [PubMed] [Google Scholar]
  27. Ferrannini E, Perniola T, Krajewska G, et al. Schwartz-Jampel syndrome with autosomal-dominant inheritance. Eur Neurol 1982 ; 21 : 137–146. [CrossRef] [PubMed] [Google Scholar]
  28. Spaans F.. Schwartz-Jampel syndrome with dominant inheritance (Letter). Muscle Nerve 1991 ; 14 : 1142. [PubMed] [Google Scholar]
  29. Iwata S, Ito M, Nakata T, et al. A missense mutation in domain III in HSPG2 in Schwartz-Jampel syndrome compromises secretion of perlecan into the extracellular space. Neuromuscul Disord 2015 ; 25 : 667–671. [CrossRef] [PubMed] [Google Scholar]
  30. Das Bhowmik A, Dalal A, Matta D, et al. Identification of a novel splice site HSPG2 mutation and prenatal diagnosis in Schwartz Jampel Syndrome type 1 using whole exome sequencing. Neuromuscul Disord 2016; 26 : 809–14. [CrossRef] [PubMed] [Google Scholar]
  31. Yan W, Dai J, Shi D, et al. Novel HSPG2 mutations causing Schwartz-Jampel syndrome type 1 in a Chinese family: a case report. Mol Med Rep 2018 ; 18 : 1761–1765. [PubMed] [Google Scholar]
  32. Stum M, Davoine CS, Vicart S, et al. Spectrum of HSPG2 (perlecan) mutations in patients with Schwartz-Jampel syndrome. Hum Mutat 2006 ; 27 : 1082–1091. [CrossRef] [PubMed] [Google Scholar]
  33. Martinez JR, Dhawan A, Farach-Carson MC. Modular Proteoglycan Perlecan/HSPG2: mutations, phenotypes, and functions. Genes 2018 ; 9 : 556. [CrossRef] [PubMed] [Google Scholar]
  34. Kallunki P, Eddy RL, Byers MG, et al. Cloning of human heparan sulfate proteoglycan core protein, assignment of the gene (HSPG2) to 1p36.1-p35 and identification of a BamHI restriction fragment length polymorphism. Genomics 1991 ; 11 : 389–396. [CrossRef] [PubMed] [Google Scholar]
  35. Noonan DM, Fulle A, Valente P, et al. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule. J Biol Chem 1991 ; 266 : 22939–22947. [CrossRef] [PubMed] [Google Scholar]
  36. Graham LD, Whitelock JM, Underwood PA. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains. Biochem Biophys Res Commun 1999 ; 256 : 542–548. [CrossRef] [Google Scholar]
  37. Xu Z, Ichikawa N, Kosaki K, et al. Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition. Matrix Biol 2010 ; 29 : 461–470. [CrossRef] [PubMed] [Google Scholar]
  38. Ning L, Xu Z, Furuya N, et al. Perlecan inhibits autophagy to maintain muscle homeostasis in mouse soleus muscle. Matrix Biol 2015 ; 48 : 26–35. [CrossRef] [PubMed] [Google Scholar]
  39. Pei S, Parthasarathy S, Parajuli A, et al. Perlecan/Hspg2 deficiency impairs bone’s calcium signaling and associated transcriptome in response to mechanical loading. Bone 2020; 131 : 115078. [CrossRef] [PubMed] [Google Scholar]
  40. Bauche S, Boerio D, Davoine CS, et al. Peripheral nerve hyperexcitability with preterminal nerve and neuromuscular junction remodeling is a hallmark of Schwartz-Jampel syndrome. Neuromuscul Disord 2013 ; 23 : 998–1009. [CrossRef] [PubMed] [Google Scholar]
  41. Arikawa-Hirasawa E, Wilcox WR, Yamada Y. Dyssegmental dysplasia, Silverman-Handmaker type: unexpected role of perlecan in cartilage development. Am J Med Genet 2001 ; 106 : 254–257. [CrossRef] [PubMed] [Google Scholar]
  42. Arikawa-Hirasawa E, Rossi SG, et al. Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice. Nat Neurosci 2002 ; 5 : 119–123. [CrossRef] [PubMed] [Google Scholar]
  43. Nicole S, Topaloglu H, Fontaine B. 102nd ENMC International Workshop on Schwartz-Jampel syndrome, 14–16 December, 2001, Naarden. The Netherlands. Neuromuscul Disord 2003 ; 13 : 347–351. [CrossRef] [Google Scholar]
  44. Spaans F, Wagenmakers A, Saris W, et al. Procainamide therapy, physical performance and energy expenditure in the Schwartz-Jampel syndrome. Neuromuscul Disord 1991 ; 1 : 371–374. [CrossRef] [PubMed] [Google Scholar]
  45. Gurbuz G, Albayrak HM. Schwartz Jampel syndrome responding positively to carbamazepine therapy: a case report and a novel mutation. Turk J Pediatr 2019 ; 61 : 967–970. [CrossRef] [PubMed] [Google Scholar]
  46. Yamashita Y, Nakada S, Nakamura K, et al. Evaluation of human-induced pluripotent stem cells derived from a patient with Schwartz-Jampel syndrome revealed distinct hyperexcitability in the skeletal muscles. Biomedicines 2023; 11 : 814. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.